CHE FY 2025 Earnings Report — Chemed Corporation Revenue & Financial Results | Market Cap Arena

Chemed CorporationCHE

FY 2025 Earnings

Reported February 27, 2026

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2025	Prior Q	FY 2024	QoQ Change	YoY Change
Revenue	$2.5B	—	$2.4B	—	4.1%
Op. Income	$338M	—	$366M	—	-7.7%
Gross Margin	30.0%	—	35.1%	—	-5.2pp
Net Margin	10.5%	—	12.4%	—	-1.9pp
EPS (Diluted)	$18.42	—	$19.89	—	-7.4%
Free Cash Flow	$325M	—	$368M	—	-11.5%

Revenue Flow

Item	Amount
REVENUE	$2.5B
Cost of Revenue	$1.8B
GROSS PROFIT	$758M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$417M
Other Expenses	$0
Operating Expenses	$417M
Cost & Expenses	$2.2B
OPERATING INCOME	$338M
Interest Income	$9M
Interest Expense	$2M
Other Income/Expenses	$18M
INCOME BEFORE TAX	$356M
Income Tax Expense	$91M
Net Income from Continuing Ops	$265M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$265M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$265M
D&A	$65M
EBIT	$358M
EBITDA	$422M
EPS	$18
EPS Diluted	$18

Income Statement

Item	Amount
REVENUE	$2.5B
Cost of Revenue	$1.8B
GROSS PROFIT	$758M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$417M
Other Expenses	$0
Operating Expenses	$417M
Cost & Expenses	$2.2B
OPERATING INCOME	$338M
Interest Income	$9M
Interest Expense	$2M
Other Income/Expenses	$18M
INCOME BEFORE TAX	$356M
Income Tax Expense	$91M
Net Income from Continuing Ops	$265M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$265M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$265M
D&A	$65M
EBIT	$358M
EBITDA	$422M
EPS	$18
EPS Diluted	$18

Cash Flow Statement

Item	Amount
Net Income	$265M
Depreciation & Amortization	$65M
Stock-Based Compensation	$5M
Deferred Income Tax	-$6M
Other Non-Cash Items	$36M
Change in Working Capital	$24M
OPERATING CASH FLOW	$388M
Capital Expenditure	-$63M
Acquisitions (Net)	-$225.0K
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$4M
NET CASH FROM INVESTING	-$59M
Net Debt Issuance	$11M
Common Stock Repurchased	-$432M
Common Dividends Paid	-$32M
Other Financing Activities	-$8M
NET CASH FROM FINANCING	-$433M
FREE CASH FLOW	$325M
Net Change in Cash	-$104M

Balance Sheet

Item	Amount
Cash & Equivalents	$75M
Short-Term Investments	$0
Net Receivables	$183M
Inventory	$8M
Other Current Assets	$0
TOTAL CURRENT ASSETS	$303M
PP&E (Net)	$337M
Goodwill	$667M
Intangible Assets	$83M
Long-Term Investments	$140M
Tax Assets	$102M
Other Non-Current Assets	$9M
TOTAL NON-CURRENT ASSETS	$1.3B
TOTAL ASSETS	$1.6B
Account Payables	$53M
Short-Term Debt	$52M
Deferred Revenue	$0
Other Current Liabilities	$121M
TOTAL CURRENT LIABILITIES	$287M
Long-Term Debt	$0
Deferred Revenue NC	$136M
Deferred Tax Liabilities	$121M
Other Non-Current Liabilities	$13M
TOTAL NON-CURRENT LIABILITIES	$373M
TOTAL LIABILITIES	$661M
Common Stock	$38M
Additional Paid-In Capital	$1.6B
Retained Earnings	$3.0B
Treasury Stock	-$3.6B
Accum. Other Comp. Income	$2M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$979M
Minority Interest	$0
TOTAL EQUITY	$979M
TOTAL LIABILITIES & EQUITY	$1.6B
Total Debt	$155M
Net Debt	$80M